Literature DB >> 26522013

Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels.

Kaori Shimizu1, Nidia Quillinan2, James E Orfila1, Paco S Herson3.   

Abstract

OBJECTIVE: Sirtuins (Sirt) are a class of deacetylase enzymes that play an important role in cell proliferation. Sirt2 activation produces O-acetylated-ADPribose (OAADPr) which can act as a ligand for transient receptor potential cation channel, M2 (TRPM2). We tested the hypothesis that Sirt2 is activated following global cerebral ischemia and contributes to neuronal injury through activation of TRPM2.
METHODS: Adult male and female mice (8-12 weeks old) C57Bl/6 and TRPM2 knock-out mice were subjected to 8 min of cardiac arrest followed by cardiopulmonary resuscitation (CA/CPR). The Sirt2 inhibitor AGK-2 was administered intravenously 30 min after resuscitation. Hippocampal CA1 injury was analyzed at 3 days after CA/CPR. Acute Sirt2 activity was analyzed at 3 and 24 h after CA/CPR. Long-term hippocampal function was assessed using slice electrophysiology 7 days after CA/CPR.
RESULTS: AGK-2 significantly reduced CA1 injury in WT but not TRPM2 knock-out males and had no effect on CA1 injury in females. Elevated Sirt2 activity was observed in hippocampal tissue from males at 24 h after cardiac arrest and was reduced by AGK-2. In contrast, Sirt2 activity in females was increased at 3 but not 24 h. Finally, we observed long-term benefit of AGK-2 on hippocampal function, with a protection of long-term potentiation at CA1 synapses at 7 and 30 days after ischemia.
CONCLUSIONS: In summary, we observed a male specific activation of Sirt2 that contributes to neuronal injury and functional deficits after ischemia specifically in males. These results are consistent with a role of Sirt2 in activating TRPM2 following global ischemia in a sex specific manner. These results support the growing body of literature showing that oxidative stress mechanisms predominate in males and converge on TRPM2 activation as a mediator of cell death.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Cerebral ischemia; Sirtuin; TRPM2

Mesh:

Substances:

Year:  2015        PMID: 26522013      PMCID: PMC5193101          DOI: 10.1016/j.expneurol.2015.10.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

1.  SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.

Authors:  Ruth Luthi-Carter; David M Taylor; Judit Pallos; Emmanuel Lambert; Allison Amore; Alex Parker; Hilary Moffitt; Donna L Smith; Heike Runne; Ozgun Gokce; Alexandre Kuhn; Zhongmin Xiang; Michele M Maxwell; Steven A Reeves; Gillian P Bates; Christian Neri; Leslie M Thompson; J Lawrence Marsh; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

2.  Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.

Authors:  K G Tanner; J Landry; R Sternglanz; J M Denu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  TRPM2 channel activation following in vitro ischemia contributes to male hippocampal cell death.

Authors:  S Verma; N Quillinan; Y-F Yang; S Nakayama; J Cheng; M H Kelley; P S Herson
Journal:  Neurosci Lett       Date:  2012-10-02       Impact factor: 3.046

Review 4.  Sex, sex steroids, and brain injury.

Authors:  Paco S Herson; Ines P Koerner; Patricia D Hurn
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

5.  Increasing small conductance Ca2+-activated potassium channel activity reverses ischemia-induced impairment of long-term potentiation.

Authors:  J E Orfila; K Shimizu; A K Garske; G Deng; J Maylie; R J Traystman; N Quillinan; J P Adelman; P S Herson
Journal:  Eur J Neurosci       Date:  2014-07-31       Impact factor: 3.386

6.  Sex differences in caspase activation after stroke.

Authors:  Fudong Liu; Zhong Li; Jun Li; Chad Siegel; Rongwen Yuan; Louise D McCullough
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

Review 7.  Gender and the injured brain.

Authors:  Kamila Vagnerova; Ines P Koerner; Patricia D Hurn
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

8.  Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway--do androgens matter?

Authors:  K Vagnerova; K Liu; A Ardeshiri; J Cheng; S J Murphy; P D Hurn; P S Herson
Journal:  Neuroscience       Date:  2009-12-24       Impact factor: 3.590

Review 9.  Pathways to ischemic neuronal cell death: are sex differences relevant?

Authors:  Jesse T Lang; Louise D McCullough
Journal:  J Transl Med       Date:  2008-06-23       Impact factor: 5.531

10.  Sex Steroids Do Not Modulate TRPM2-Mediated Injury in Females following Middle Cerebral Artery Occlusion(1,2,3).

Authors:  Nidia Quillinan; Himmat Grewal; Jelena Klawitter; Paco S Herson
Journal:  eNeuro       Date:  2014-11-12
View more
  19 in total

Review 1.  The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.

Authors:  Nathalie Khoury; Kevin B Koronowski; Juan I Young; Miguel A Perez-Pinzon
Journal:  Antioxid Redox Signal       Date:  2017-08-07       Impact factor: 8.401

2.  Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels.

Authors:  Robert M Dietz; Ivelisse Cruz-Torres; James E Orfila; Olivia P Patsos; Kaori Shimizu; Nicholas Chalmers; Guiying Deng; Erika Tiemeier; Nidia Quillinan; Paco S Herson
Journal:  Transl Stroke Res       Date:  2019-06-28       Impact factor: 6.829

Review 3.  Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target.

Authors:  Ehsan Dadgostar; Shiva Rahimi; Shahin Nikmanzar; Sina Nazemi; Mojtaba Naderi Taheri; Zahra Alibolandi; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurochem Res       Date:  2022-01-28       Impact factor: 3.996

4.  Endogenous Sex Steroids Dampen Neuroinflammation and Improve Outcome of Traumatic Brain Injury in Mice.

Authors:  Amy C Clevenger; Hoon Kim; Ernesto Salcedo; Joan C Yonchek; Krista M Rodgers; James E Orfila; Robert M Dietz; Nidia Quillinan; Richard J Traystman; Paco S Herson
Journal:  J Mol Neurosci       Date:  2018-02-15       Impact factor: 3.444

5.  Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia.

Authors:  Takeru Shimizu; Robert M Dietz; Ivelisse Cruz-Torres; Frank Strnad; Ana K Garske; Myriam Moreno; Venugopal R Venna; Nidia Quillinan; Paco S Herson
Journal:  Exp Neurol       Date:  2016-06-15       Impact factor: 5.330

6.  Autonomous CaMKII Activity as a Drug Target for Histological and Functional Neuroprotection after Resuscitation from Cardiac Arrest.

Authors:  Guiying Deng; James E Orfila; Robert M Dietz; Myriam Moreno-Garcia; Krista M Rodgers; Steve J Coultrap; Nidia Quillinan; Richard J Traystman; K Ulrich Bayer; Paco S Herson
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 7.  TRPM2: a candidate therapeutic target for treating neurological diseases.

Authors:  Jillian Corinne Belrose; Michael Frederick Jackson
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

8.  Increasing the TRPM2 Channel Expression in Human Neuroblastoma SH-SY5Y Cells Augments the Susceptibility to ROS-Induced Cell Death.

Authors:  Xinfang An; Zixing Fu; Chendi Mai; Weiming Wang; Linyu Wei; Dongliang Li; Chaokun Li; Lin-Hua Jiang
Journal:  Cells       Date:  2019-01-08       Impact factor: 6.600

9.  Analysis of the CaMKIIα and β splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation.

Authors:  Sarah G Cook; Ashley M Bourke; Heather O'Leary; Vincent Zaegel; Erika Lasda; Janna Mize-Berge; Nidia Quillinan; Chandra L Tucker; Steven J Coultrap; Paco S Herson; K Ulrich Bayer
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

Review 10.  TRPM2 in the Brain: Role in Health and Disease.

Authors:  Giulia Sita; Patrizia Hrelia; Agnese Graziosi; Gloria Ravegnini; Fabiana Morroni
Journal:  Cells       Date:  2018-07-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.